Diabetic foot ulcers are more costly to treat than the five leading cancers. In response, UAHS physician-scientists David Armstrong, DPM, MD, PhD, and Marvin Slepian, MD, have begun discussions with Cuban researchers to steward the FDA approval for a diabetic foot ulcer healing drug for use in the United States.